Importance The mortality rate for the most advanced forms of heart failure with medical
therapy alone remains unacceptably high at 30% to 80% at 1 year. In the past decade, left …

Long-term mechanical circulatory support (LT-MCS) is an important treatment modality for
patients with severe heart failure. Different devices are available, and many—sometimes …

With increasingly large sample sizes required to demonstrate event reduction, heart failure
outcome trials are no longer being performed in a small group of selected patients and …

Background: Although human mesenchymal stem cells (hMSCs) have been tested in
ischemic cardiomyopathy, few studies exist in chronic nonischemic dilated cardiomyopathy …

A transthoracic echocardiogram is recommended in patients with suspected heart failure, to
improve diagnostic accuracy, and in patients with a new diagnosis of heart failure, to assess …

Abstract OBJECTIVES The European Registry for Patients with Mechanical Circulatory
Support (EUROMACS) was founded in Berlin, Germany. EUROMACS is supported fully by …

The second annual IMACS registry report includes over 14, 000 patients from 35 countries.
Survival, adverse events, and an updated risk model is presented. Continuous flow pumps …

Background In Spain, listing for high‐urgent heart transplantation is allowed for critically ill
candidates not weanable from temporary mechanical circulatory support (T‐MCS). We …

Abstract Background The HeartMate 3 Left Ventricular Assist System (LVAS)(St. Jude
Medical Inc., St Paul, MN) with full magnetic levitation allows for wide and consistent blood …

Aim This study aimed to assess safety and outcomes of patients, 2 years after implantation
with the HeartMate 3 Left Ventricular Assist System. Methods and results This study included …